Inolife Technologies Inc.

<ul> <li>Can have professionals with minimal training administer the drugs (no nurse practitioner required)</li> <li>No extensive sterilization or needle waste disposal costs</li> <li>Drastically reduce returns due to injection site infections (currently 6%-8% of all injections)</li> <li>Reduce patient anxiety and times for patient visit, especially in pediatrics</li> <li>Can be administered virtually anywhere on the body (no &ldquo;vein-hunting&rdquo;)</li> <li>Eliminates needle stick injuries that affect 2 million health care workers per year</li> </ul>

<ul> <li>No dangerous medical waste disposal, eliminating a cost of $30-$50 / liter / day for more than 6000 institutions in Canada/USA alone</li> <li>Drastic reduction in site contamination and infection (occurs in 6%-8% of injections)</li> <li>Creates great appeal for pain-free clinics (pediatric, dental&hellip;)</li> <li>Similar costs and coverage as syringe-based regimen</li> <li>Elimination of needlestick injuries and resulting staff downtime - 3000 occur in hospitals every day, with costs and damage ranging from $5000 per incident and absenteeism to massive claims</li> <li>Device designed to be reused without sterilization</li> <li>Compliance with sharps incidents requirements (federal and state law) are also greatly reduced</li> </ul>

<p>If you are a health insurance company, these are the benefits in working with us;&nbsp;</p> <ul> <li>Enables inexpensive home-based self-care</li> <li>Improves adherence to drug regimens, better outcomes and reduced complications</li> <li>Reduced incidence of site infection and return visits</li> <li>Eliminates needlestick injuries and resulting staff insurance claims</li> </ul> <p>If &nbsp;you are a drug developer, whether you are an innovator, biosimilar or generic provider;&nbsp;</p> <ul> <li>Better adherence yields better outcome statistics</li> <li>Less adjuvants and excipients results in lower costs per dose</li> <li>Better tolerance than oral doses &ndash; reduced stomach ulcers, oral complications</li> <li>Drastically lower dose costs in powder formulation (for our next generation product)</li> <li>Co-packing opportunities can reduce&nbsp;medical errors in dosing, and risk of spoilage in handling</li> <li>Possibility of extending patent life of key drugs &ndash; longer profit life - ask us about it!</li> </ul>